PUBLICATION
Anti-Parkinson's Disease Activity of Sanghuangprous vaninii Extracts in the MPTP-Induced Zebrafish Model
- Authors
- Li, X., Gao, D., Paudel, Y.N., Li, X., Zheng, M., Liu, G., Ma, Y., Chu, L., He, F., Jin, M.
- ID
- ZDB-PUB-220120-5
- Date
- 2022
- Source
- ACS Chemical Neuroscience 13(3): 330-339 (Journal)
- Registered Authors
- Keywords
- MPTP, Parkinson disease, Sanghuangprous vaninii, antioxidant, extract, α-synuclein
- MeSH Terms
-
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Animals
- Basidiomycota*
- Disease Models, Animal
- Dopaminergic Neurons/metabolism
- MPTP Poisoning*/pathology
- Mice
- Mice, Inbred C57BL
- Neuroprotective Agents*/pharmacology
- Quality of Life
- Zebrafish
- PubMed
- 35044760 Full text @ ACS Chem. Neurosci.
Citation
Li, X., Gao, D., Paudel, Y.N., Li, X., Zheng, M., Liu, G., Ma, Y., Chu, L., He, F., Jin, M. (2022) Anti-Parkinson's Disease Activity of Sanghuangprous vaninii Extracts in the MPTP-Induced Zebrafish Model. ACS Chemical Neuroscience. 13(3):330-339.
Abstract
Parkinson's disease (PD) is a devastating disease of the central nervous system that occurs mainly in the elderly age group, affecting their quality of life. The PD pathogenesis is not yet fully understood and lacks the disease-modifying treatment strategies. Sanghuangprous vaninii (S. vaninii) is a perennial fungus with a plethora of pharmacological activities including anti-cancer and antioxidant activity and so on. However, no study till date has reported its neuroprotective effect against symptoms that are similar to PD in pre-clinical investigation. In the current study, we investigated anti-PD-like effects of S. vaninii mycelium extracts (SvMEs) on MPTP-induced PD in zebrafish. We observed that the loss of dopaminergic neurons and neurovascular reduction were reversed by using SvMEs in the zebrafish brain in a concentration-independent manner. Moreover, it also relieved locomotor impairments in MPTP-induced PD zebrafish. In addition, SvMEs exerted significant antioxidant activity in vitro, which was also demonstrated in vivo on ktr4:NTR-hKikGR zebrafish. Upon investigating the underlying mechanism, we found that SvMEs may alleviate oxidant stress and accelerate α-synuclein degradation and then alleviate PD-like symptoms. Antioxidant-related genes (sod1, gss, gpx4a, gclm, and cat) implied that the SvMEs exhibited anti-PD activity due to the antioxidation mechanism. Finally, upon analysis of chemical composition of SvMEs by liquid chromatography-mass spectrometry, we identified 10 compounds that are plausibly responsible for the anti-PD-like effect of SvMEs. On the limiting part, the finding of the study would have been more robust had we investigated the protein expression of genes related to PD and oxidative stress and compared the effects of SvMEs with any standard anti-PD therapy. Despite this, our results indicated that SvMEs possess anti-PD effects, indicating SvMEs as a potential candidate that is worth exploring further in this avenue.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping